Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Fat grafting for pedal fat pad atrophy: A narrative review of the literature.

Bcharah G., Tummala SV., Braithwaite CL., Karsen PJ., Patel KA.

Narrative Review on Ankle & Foot, published in J Foot Ankle Surg (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Foot Ankle Surg (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
40683455
DOI
10.1053/j.jfas.2025.07.008

Abstract (original English)

Introduction Pedal fat pad atrophy involves the loss of shock-absorbing adipose tissue beneath the foot, causing pain, reduced mobility, and risk of skin breakdown. Autologous fat grafting has gained attention as a regenerative approach that restores natural cushioning rather than merely masking symptoms. Methods PubMed, Web of Science, and Google Scholar were searched through 02/01/2025 for studies on autologous fat grafting for pedal fat pad atrophy of any etiology. Data regarding pain relief, functional outcomes, complications, and comparisons with orthotics, dermal fillers, silicone implants, and allograft adipose matrix were examined. Results Autologous fat grafting demonstrated substantial, sustained pain reduction and improved foot function in multiple studies. Randomized trials showed superior outcomes over conservative management, with decreased pain scores and enhanced mobility persisting up to two years post-procedure. Imaging assessments indicated stable or redistributed graft volume correlating with long-term symptom relief. Complications were minimal, typically limited to minor bruising or temporary discomfort. Comparisons revealed that while dermal fillers provide short-term cushioning and silicone implants pose regulatory concerns, allograft adipose matrix also exhibits regenerative effects similar to autologous fat grafting but without donor-site morbidity. Con

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAdipose TissueAtrophyTransplantation, Autologous

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research